Mobile health monitoring to characterize depression symptom trajectories in primary care.

BACKGROUND Classification of depression severity can guide treatment decisions. This study examined whether using repeated mobile health assessments to determine symptom trajectories is a potentially useful method for classifying depression severity. METHODS 344 primary care patients with depression were identified and recruited as part of a program of mobile health symptom monitoring and self-management support. Depression symptoms were measured weekly via interactive voice response (IVR) calls using the Patient Health Questionnaire (PHQ-9). Trajectory analysis of weekly IVR PHQ-9 scores from baseline through week 6 was used to subgroup patients according to similar trajectories. Multivariable linear regression was used to determine whether the trajectories predicted 12-week PHQ-9 scores after adjusting for baseline and 6-week PHQ-9 scores. RESULTS The optimal trajectory analysis model included 5 non-intersecting trajectories. The subgroups of patients assigned to each trajectory had mean baseline PHQ-9s of 19.7, 14.5, 9.5, 5.0, and 2.0, and respective mean decreases in PHQ-9s over six weeks of .3, 2.0, 3.6, 2.3, and 1.9. In regression analyses, each trajectory significantly predicted 12-week PHQ-9 scores (using the modal trajectory as a reference) after adjusting for both baseline and 6-week PHQ-9 scores. LIMITATIONS Treatment history was unknown, findings may not be generalizable to new episodes of treatment. CONCLUSIONS Depression symptom trajectories based on mobile health assessments are predictive of future depression outcomes, even after accounting for typical assessments at baseline and a single follow-up time point. Approaches to classify patients׳ disease status that involve multiple repeated assessments may provide more accurate and useful information for depression management compared to lower frequency monitoring.

[1]  J. Markowitz,et al.  Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. , 2000, The American journal of psychiatry.

[2]  A. Malla,et al.  The pattern of depressive symptoms in people with type 2 diabetes: a prospective community study. , 2013, Journal of psychosomatic research.

[3]  R. Spitzer,et al.  The PHQ-9: A new depression diagnostic and severity measure , 2002 .

[4]  Alex J Sutton,et al.  Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. , 2006, Archives of internal medicine.

[5]  S. Folkman,et al.  Depression, distress and positive mood in late‐stage cancer: a longitudinal study , 2009, Psycho-oncology.

[6]  L. Rubenstein,et al.  Wishing upon a STAR*D: the promise of ideal depression care by primary care providers. , 2009, Psychiatric services.

[7]  Do Peterson,et al.  Collaborative care for patients with depression and chronic illnesses. , 2010, The New England journal of medicine.

[8]  P. Skorga,et al.  Collaborative care for depression and anxiety problems , 2013 .

[9]  K. Roeder,et al.  A SAS Procedure Based on Mixture Models for Estimating Developmental Trajectories , 2001 .

[10]  S. Dikmen,et al.  Rates of major depressive disorder and clinical outcomes following traumatic brain injury. , 2010, JAMA.

[11]  A. Kilbourne,et al.  Comparative Effectiveness of Collaborative Chronic Care Models for Mental Health Conditions Across Primary, Specialty, and Behavioral Health Care Settings: Systematic Review and Meta-Analysis , 2013 .

[12]  R. Spitzer,et al.  The PHQ-9: validity of a brief depression severity measure. , 2001, Journal of general internal medicine.

[13]  M. Fava,et al.  Primary Versus Specialty Care Outcomes for Depressed Outpatients Managed with Measurement-Based Care: Results from STAR*D , 2008, Journal of General Internal Medicine.

[14]  Dawn M. Klein,et al.  Validity of the Patient Health Questionnaire, PHQ-9, administered through interactive-voice-response technology , 2012, Journal of telemedicine and telecare.

[15]  M. Heo,et al.  Re-engineering systems for the treatment of depression in primary care: cluster randomised controlled trial , 2004, BMJ : British Medical Journal.

[16]  S. Roose,et al.  Does Study Design Influence Outcome? , 2009, Psychotherapy and Psychosomatics.

[17]  G. Simon,et al.  Does response on the PHQ-9 Depression Questionnaire predict subsequent suicide attempt or suicide death? , 2013, Psychiatric services.

[18]  Implementing standardized assessments in clinical care: now's the time. , 2009, Psychiatric services.

[19]  L. Marangell,et al.  COMPREHENSIVE REVIEW OF FACTORS IMPLICATED IN THE HETEROGENEITY OF RESPONSE IN DEPRESSION , 2012, Depression and anxiety.

[20]  S. Patten,et al.  Longitudinal epidemiology of major depression as assessed by the Brief Patient Health Questionnaire (PHQ-9). , 2009, Comprehensive psychiatry.

[21]  B. Lebowitz,et al.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. , 2006, The American journal of psychiatry.

[22]  W. Katon,et al.  A multifaceted intervention to improve treatment of depression in primary care. , 1996, Archives of general psychiatry.

[23]  J. Piette,et al.  Depression self-management assistance using automated telephonic assessments and social support. , 2013, The American journal of managed care.

[24]  J. Ware,et al.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. , 1996, Medical care.